About SetPoint Medical

Sponsor retains sole responsibility for content.

SetPoint Medical is a privately held biomedical technology company dedicated to treating patients with debilitating inflammatory diseases using bioelectronic therapy. SetPoint’s approach is intended to offer patients and providers an alternative for the treatment of rheumatoid arthritis (RA) and other chronic inflammatory diseases with less risk and cost than drug therapy. SetPoint is developing...

SetPoint Medical is a privately held biomedical technology company dedicated to treating patients with debilitating inflammatory diseases using bioelectronic therapy. SetPoint’s approach is intended to offer patients and providers an alternative for the treatment of rheumatoid arthritis (RA) and other chronic inflammatory diseases with less risk and cost than drug therapy. SetPoint is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate the body’s natural Inflammatory Reflex, which is intended to produce a potent systemic anti-inflammatory effect. The company has published positive results from a first-in-human open-label proof-of-concept trial in rheumatoid arthritis in Proceedings of the National Academy of Sciences (PNAS) and presented positive results at the American College of Rheumatology meeting. Current investors in the company include Morgenthaler Ventures, NEA, Topspin Partners, Medtronic, GlaxoSmithKline’s Action Potential Venture Capital Limited and Boston Scientific.

Contact SetPoint Medical

Phone Number
(661) 750-6140

More About SetPoint Medical

Therapeutic Areas
  • Inflammation
Technologies
  • Medical device
  • Other
Company Type
  • Biotechnology – Therapeutics
State of Ownership
  • Private
Sponsorship Group
  • Leader
Go to the profile of Andrew Marshall

Andrew Marshall

Chief Editor, Nature Biotechnology, Nature Publishing Group

Go to the profile of Christine Borowski

Christine Borowski

Chief Editor, Nature Medicine, Nature Publishing Group

Go to the profile of Claire Thompson

Claire Thompson

Global Manager, Business Development, Nature Publishing Group

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Go to the profile of Peter Kirkpatrick

Peter Kirkpatrick

Chief Editor, Nature Reviews Drug Discovery, Nature Publishing Group

Go to the profile of Samia Burridge

Samia Burridge

Business Development Manager, Global Sponsorship, Nature Research Group

Go to the profile of Veronica Zacatenco

Veronica Zacatenco

Business Development Executive, Nature Publishing Group

Go to the profile of Georgia Francis

Georgia Francis

Editorial Assistant, BioPharm Dealmakers, Nature Publishing Group

Go to the profile of Carmen Ramirez

Carmen Ramirez

Sales Account Executive, Springer Nature